Zhong Chao Han
Presidente presso Tianjin Amcellgene Engineering Co., Ltd.
Posizioni attive di Zhong Chao Han
Società | Posizione | Inizio | Fine |
---|---|---|---|
Tianjin Amcellgene Engineering Co., Ltd.
Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Presidente | - | - |
Direttore Tecnico/Scientifico/R&S | - | - | |
Beijing Health & Biotech Co., Ltd.
Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Presidente | - | - |
Storia della carriera di Zhong Chao Han
Statistiche
Distribuzione geografica
Cina | 3 |
Posizioni
Chairman | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Tianjin Amcellgene Engineering Co., Ltd.
Tianjin Amcellgene Engineering Co., Ltd. BiotechnologyHealth Technology Tianjin Amcellgene Engineering Co., Ltd. engages in the research and development of cell therapeutic products. It offers human adipose-derived, human umbilical cord, and human amniotic membrane-derived mesenchymal stem cells. The company was founded in August 2004 and is headquartered in Tianjin, China. | Health Technology |
Beijing Health & Biotech Co., Ltd.
Beijing Health & Biotech Co., Ltd. BiotechnologyHealth Technology Beijing Health & Biotech Co., Ltd. engages in the development of stem cell technologies. Its business offers diabetes therapy, cardiovascular diseases therapy, neurological diseases therapy, autoimmune diseases therapy, limb ischemic disease therapy, sub-health and anti-aging therapy, and stem cell banking. The company was founded on January 8, 2007 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Zhong Chao Han
- Esperienza